Yale University

Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.

TitleOptimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
Publication TypeJournal Article
Year of Publication2005
AuthorsKimmel, April D., Sue J. Goldie, Rochelle P. Walensky, Elena Losina, Milton C. Weinstein, David A. Paltiel, Hong Zhang, and Kenneth A. Freedberg
Corporate AuthorsCost-Effectiveness of Preventing AIDS Complications Investigators
JournalAntiviral therapy
Volume10
Issue1
Pagination41-52
Date Published2005
ISSN1359-6535
KeywordsAnti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Computer Simulation, Cost-Benefit Analysis, HIV Infections, Humans, Models, Biological, Models, Economic, Outcome Assessment (Health Care), RNA, Viral, Sensitivity and Specificity, Time Factors, Virology
AbstractGuidelines regarding the frequency of CD4 cell count and HIV RNA monitoring in HIV-infected patients vary, with recommended strategies ranging from every 2 to every 6 months.
DOI10.1111/j.1524-4733.2010.00763.x
Alternate JournalAntivir. Ther. (Lond.)

External Links